Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.27% | -8.11% | -3.49% | 3.36% | 14.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.27% | -8.11% | -3.49% | 3.36% | 14.25% |
| Cost of Revenue | -0.57% | 0.82% | 11.55% | 12.64% | 16.86% |
| Gross Profit | -9.52% | -13.03% | -11.33% | -1.62% | 12.81% |
| SG&A Expenses | -16.11% | -10.66% | -5.36% | -0.20% | 1.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.38% | -7.40% | -0.73% | 3.91% | 6.24% |
| Operating Income | 27.08% | 5.54% | -6.10% | -5.11% | 9.10% |
| Income Before Tax | 13.58% | -9.52% | -60.11% | -55.36% | -0.91% |
| Income Tax Expenses | 321.43% | 110.36% | 110.56% | 93.60% | 94.31% |
| Earnings from Continuing Operations | 12.08% | -24.98% | -86.54% | -73.51% | -9.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.96% | -29.93% | -39.71% | -11.57% | -15.00% |
| Net Income | 12.14% | -25.38% | -87.67% | -74.14% | -10.06% |
| EBIT | 27.08% | 5.54% | -6.10% | -5.11% | 9.10% |
| EBITDA | 27.61% | 5.26% | -7.01% | -5.88% | 8.45% |
| EPS Basic | 16.76% | -23.04% | -87.53% | -73.88% | -9.79% |
| Normalized Basic EPS | 16.85% | -9.89% | -22.96% | -19.77% | -0.22% |
| EPS Diluted | 16.76% | -23.04% | -87.53% | -73.88% | -9.79% |
| Normalized Diluted EPS | 16.85% | -9.89% | -22.96% | -19.77% | -0.22% |
| Average Basic Shares Outstanding | 7.00% | 2.64% | 0.10% | 0.15% | 0.22% |
| Average Diluted Shares Outstanding | 7.00% | 2.64% | 0.10% | 0.15% | 0.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |